Inventor · disambiguated record
Tae Kyo Park
Also filed as: PARK TAE-KYO
22 granted patents·3 pending applications·150 citations·filing 1995–2019
94Inventor score
Files withCHO YOUNG LAG7LEGOCHEM BIOSCIENCES INC5SLOAN KETTERING INST CANCER3GREEN CROSS CORP1GWAK HYUNG SUB1
Top patents by PatentIndex Score
25 records- 0196US10980890B2Compounds comprising self-immolative groupLEGOCHEM BIOSCIENCES INC·Filed 2019·Granted Apr 20, 2021·12 cites·22 claims
- 0294US9919057B2Compounds comprising self-immolative groupLEGOCHEM BIOSCIENCES INC·Filed 2015·Granted Mar 20, 2018·20 cites·20 claims
- 0393US9993568B2Compounds comprising self-immolative groupLEGOCHEM BIOSCIENCES INC·Filed 2015·Granted Jun 12, 2018·14 cites·25 claims
- 0491US10383949B2Compounds comprising self-immolative groupLEGOCHEM BIOSCIENCES INC·Filed 2018·Granted Aug 20, 2019·9 cites·21 claims
- 0583US11065343B2Compound bearing beta-galactoside-introduced self-immolative linkerINTOCELL INC·Filed 2017·Granted Jul 20, 2021·3 cites·14 claims
- 0683US6747050B1Isoxazoline derivative and a process for the preparation thereofLG CHEM INVESTMENT LTD·Filed 2000·Granted Jun 8, 2004·23 cites·13 claims
- 0781US8329684B2Cephalosporin derivatives and pharmaceutical compositions thereofCHO YOUNG LAG·Filed 2012·Granted Dec 11, 2012·7 cites·19 claims
- 0879US8178525B2FXA inhibitors with cyclic amidoxime or cyclic amidrazone as P4 subunit, processes for their preparations, and pharmaceutical compositions and derivatives thereofSONG HO YOUNG·Filed 2009·Granted May 15, 2012·5 cites·7 claims
- 0978US8242113B2Oxazolidinone derivatives with cyclic amidoxime or cyclic amidrazone pharmaceutical compositions thereofCHO YOUNG LAG·Filed 2009·Granted Aug 14, 2012·4 cites·22 claims
- 1076US8637667B2Method for preparing (S)-5-chloro-N-((3-(4-(5,6-dihydro-4H-1,2,4-oxadiazin-3-yl)phenyl)-2-oxooxazolidin-5-yl)methyl)thiophene-2-carboxamide derivativesCHO YOUNG LAG·Filed 2010·Granted Jan 28, 2014·2 cites·3 claims
- 1174US6090789ASynthesis of the breast tumor-associated antigen defined by monoclonal antibody MBr1 and uses thereofSLOAN KETTERING INST CANCER·Filed 1997·Granted Jul 18, 2000·20 cites·13 claims
- 1272US8809541B2Heterocyclic compound, and composition for treating inflammatory diseases using sameGWAK HYUNG SUB·Filed 2011·Granted Aug 19, 2014·5 cites·10 claims
- 1368US9630977B2Cephalosporin derivatives and pharmaceutical compositions thereofLEGOCHEM BIOSCIENCES INC·Filed 2012·Granted Apr 25, 2017·1 cites·19 claims
- 1467US8754210B2Method for preparing 5-chloro-N-({(5S)-2-oxo-3-[4-(5,6-dihydro-4H-[1,2,4]triazin-1-yl)phenyl]-1,3-oxazolidin-5-yl}methyl) derivative and intermediate used thereinCHO YOUNG LAG·Filed 2010·Granted Jun 17, 2014·1 cites·6 claims
- 1560US9988372B2Crystalline form of 5-chloro-N-({(5S)-2-oxo-3-[4-(5,6-dihydro-4H-[1,2,4]triazin-1-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)thiophene-2-carboxamide methanesulfonate and pharmaceutical composition comprising sameGREEN CROSS CORP·Filed 2014·Granted Jun 5, 2018·0 cites·4 claims
- 1659US5708163ASynthesis of the breast tumor-associated antigen defined by monoclonalantibody MBRL and uses thereofSLOAN KETTERING INST CANCER·Filed 1995·Granted Jan 13, 1998·10 cites·7 claims
- 1758US7557133B2Caspase inhibitors containing isoxazoline ringLG LIFE SCIENCES LTD·Filed 2004·Granted Jul 7, 2009·1 cites·21 claims
- 1856US2016213786A1Protein-active agent conjugates and methods of useKIM YONG ZU·Filed 2016·Application pending·0 cites
- 1952US6238668B1Colon cancer KH-1 and N3 antigensSLOAN KETTERING INST CANCER·Filed 1998·Granted May 29, 2001·13 cites·12 claims
- 2047US8288423B2FXa inhibitors with cyclic amidines as P4 subunit, processes for their preparations, and pharmaceutical compositions and derivatives thereofCHO YOUNG LAG·Filed 2008·Granted Oct 16, 2012·0 cites·8 claims
- 2145US2002006900A1Colon cancer KH-1 and N3 antigensFiled 2001·Application pending·0 cites
- 2244US8846669B2Oxazolidinone derivative and medical composition containing sameCHO YOUNG LAG·Filed 2012·Granted Sep 30, 2014·0 cites·12 claims
- 2341US8703939B2Method for preparing (R)-3-(3-fluoro-4-(1-methyl-5,6-dihydro-1,2,4-triazin-4(1H)-yl)phenyl)-5-(substituted methyl)oxazolidin-2-one derivativesCHO YOUNG LAG·Filed 2011·Granted Apr 22, 2014·0 cites·5 claims
- 2431US2003065176A1Factor xa inhibitors with aryl-amidines and derivatives, and prodrugs thereofFiled 2001·Application pending·0 cites
- 2529US9062066B2Anti-inflammatory compound having inhibitory activity against multiple tyrosine kinases and pharmaceutical composition containing sameYANG BEOM-SEOK·Filed 2011·Granted Jun 23, 2015·0 cites·10 claims
Join the waitlist — get patent alerts
Get an alert when Tae Kyo Park files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →